Cross Protection by Encephalitis Vaccine as a Factor for Lesser COVID Mortality

▴ Cross Protection by Encephalitis Vaccine as a Factor for Lesser COVID Mortality
"As we are not sure when a drug or vaccine will be available to relieve humankind from the clutches of this pandemic, our modest contribution through this hypothesis, we do hope may trigger similar or better thoughtful ideas," said Dr. Katoh.

A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection induced by Japanese Encephalitis Vaccine (JEV) and/or Tick-Borne Encephalitis Vaccine (TEV) according to Dr Shojiro Katoh, President, Edogawa Hospital. He along with his international team of researchers of Edogawa Evolutionary Lab of Science (EELS), have published their opinion in Archives of Academic Emergency Medicine, a peer reviewed journal

The COVID-19 pandemic with 2,478,634 people infected, and 170,000 deaths globally, has caused unprecedented implications on day-to-day life and the global economy. Loss of lives in Spain (20,852) and Italy (24,114) are more than China (4,632), the epicenter of the outbreak, where JEV and/or TEV is included in national immunization schedule, like Japan (186) and Austria (463). In China, the mortality is 2.3% compared to 7.3% in Italy and 10.41% in Spain, where JEV and/or TEV is not routine. JEV immunization is widespread, or in the national vaccination programs of Japan, Laos, Malaysia, Nepal, South Korea, Thailand, Sri Lanka, and Vietnam where the mortality rate is relatively lower than countries that don’t. Going by the above data, cross-protection conferred by the encephalitis vaccine(s) could be thought as a reason for lower mortality, which must be proven by necessary validations. If any such cross protection could be confirmed to be of help even at least for a specific group, especially the vulnerable population such as the elderly and those with co-morbid conditions, may pave way for arriving at efficient strategies for tackling COVID-19.


"As we are not sure when a drug or vaccine will be available to relieve humankind from the clutches of this pandemic, our modest contribution through this hypothesis, we do hope may trigger similar or better thoughtful ideas," said Dr. Katoh.

Tags : #NewInnovation #Covid19 #Pandemic #EncephalitisVaccine

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024